These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2553516)

  • 61. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
    Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
    Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts.
    Markmann JF; Jacobson JD; Kiumura H; Choti MA; Hickey WF; Fox IJ; Silvers WK; Barker CF; Naji A
    Transplantation; 1989 Sep; 48(3):478-86. PubMed ID: 2571205
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytotoxic T cells with reciprocal antigenic peptide presentation function are not generally resistant to mutual lysis.
    Staege MS; Gisch K; Reske-Kunz AB
    Immunol Cell Biol; 2003 Aug; 81(4):266-74. PubMed ID: 12848847
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tissue-specific expression of transfected human insulin genes in pluripotent clonal rat insulinoma lines induced during passage in vivo.
    Madsen OD; Andersen LC; Michelsen B; Owerbach D; Larsson LI; Lernmark A; Steiner DF
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6652-6. PubMed ID: 2842785
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice].
    Nagata M
    Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice.
    Bieg S; Bailyes EM; Yassin N; Amann J; Herberg L; McGregor AM; Scherbaum WA; Banga JP
    Diabetologia; 1993 May; 36(5):385-90. PubMed ID: 8314441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes.
    Norcross MA; Bentley DM; Margulies DH; Germain RN
    J Exp Med; 1984 Nov; 160(5):1316-37. PubMed ID: 6436430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
    Akbasak A; Oldfield EH; Saris SC
    J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes.
    Moots RJ; Samberg NL; Pazmany L; Frelinger JA; McMichael AJ; Stauss HJ
    Eur J Immunol; 1992 Jun; 22(6):1643-6. PubMed ID: 1601046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.